🇺🇸 FDA
Patent

US 8124084

Compositions and methods for immunomodulation in an organism using IL-15 and soluble IL-15Ra

granted A61KA61K38/00A61K38/1793

Quick answer

US patent 8124084 (Compositions and methods for immunomodulation in an organism using IL-15 and soluble IL-15Ra) held by UNIVERSITY OF CONNECTICUT expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNIVERSITY OF CONNECTICUT
Grant date
Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
47
CPC classes
A61K, A61K38/00, A61K38/1793, A61K38/2086, A61P